Cargando…

Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora

Detalles Bibliográficos
Autores principales: Long, Jianfei, Gong, Jingru, Zhu, Han, Liu, Xiaolin, Li, Ling, Chen, Bicui, Ren, Hongyan, Liu, Chao, Lu, Huiping, Zhang, Jiming, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659110/
https://www.ncbi.nlm.nih.gov/pubmed/38029071
http://dx.doi.org/10.3389/fmicb.2023.1322004
_version_ 1785137532116140032
author Long, Jianfei
Gong, Jingru
Zhu, Han
Liu, Xiaolin
Li, Ling
Chen, Bicui
Ren, Hongyan
Liu, Chao
Lu, Huiping
Zhang, Jiming
Wang, Bin
author_facet Long, Jianfei
Gong, Jingru
Zhu, Han
Liu, Xiaolin
Li, Ling
Chen, Bicui
Ren, Hongyan
Liu, Chao
Lu, Huiping
Zhang, Jiming
Wang, Bin
author_sort Long, Jianfei
collection PubMed
description
format Online
Article
Text
id pubmed-10659110
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106591102023-11-06 Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora Long, Jianfei Gong, Jingru Zhu, Han Liu, Xiaolin Li, Ling Chen, Bicui Ren, Hongyan Liu, Chao Lu, Huiping Zhang, Jiming Wang, Bin Front Microbiol Microbiology Frontiers Media S.A. 2023-11-06 /pmc/articles/PMC10659110/ /pubmed/38029071 http://dx.doi.org/10.3389/fmicb.2023.1322004 Text en Copyright © 2023 Long, Gong, Zhu, Liu, Li, Chen, Ren, Liu, Lu, Zhang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Long, Jianfei
Gong, Jingru
Zhu, Han
Liu, Xiaolin
Li, Ling
Chen, Bicui
Ren, Hongyan
Liu, Chao
Lu, Huiping
Zhang, Jiming
Wang, Bin
Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
title Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
title_full Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
title_fullStr Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
title_full_unstemmed Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
title_short Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
title_sort corrigendum: difference of gut microbiota between patients with negative and positive hbeag in chronic hepatitis b and the effect of tenofovir alafenamide on intestinal flora
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659110/
https://www.ncbi.nlm.nih.gov/pubmed/38029071
http://dx.doi.org/10.3389/fmicb.2023.1322004
work_keys_str_mv AT longjianfei corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT gongjingru corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT zhuhan corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT liuxiaolin corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT liling corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT chenbicui corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT renhongyan corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT liuchao corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT luhuiping corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT zhangjiming corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora
AT wangbin corrigendumdifferenceofgutmicrobiotabetweenpatientswithnegativeandpositivehbeaginchronichepatitisbandtheeffectoftenofoviralafenamideonintestinalflora